These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z, Kala P. Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [Abstract] [Full Text] [Related]
4. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice. Vermeer NS, Bajorek BV. J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236 [Abstract] [Full Text] [Related]
5. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF, DISPERSE-2 Investigators. J Am Coll Cardiol; 2007 Nov 06; 50(19):1844-51. PubMed ID: 17980250 [Abstract] [Full Text] [Related]
7. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM, TRILOGY ACS Steering Committee. Am Heart J; 2010 Jul 06; 160(1):16-22.e1. PubMed ID: 20598967 [Abstract] [Full Text] [Related]
10. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WB, Pollack CV, Smith SC, Ferguson TB, Peterson ED. J Am Coll Cardiol; 2006 Jul 18; 48(2):281-6. PubMed ID: 16843176 [Abstract] [Full Text] [Related]
11. Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes. El-Menyar A, AlHabib KF, Al-Motarreb A, Hersi A, Al Faleh H, Asaad N, Al Saif S, Almahmeed W, Sulaiman K, Amin H, Al-Lawati J, Alsheikh-Ali AA, AlQahtani A, Al-Sagheer NQ, Singh R, Al Suwaidi J. Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):127-35. PubMed ID: 22257172 [Abstract] [Full Text] [Related]
16. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, Dibenedetto D, Eagle KA, Mehta RH, GRACE Investigators. Eur Heart J; 2005 Jun 01; 26(11):1063-9. PubMed ID: 15716281 [Abstract] [Full Text] [Related]
17. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Carvajal J, Lehmann A, Lambert M, Bonnet JL, Alessi MC. J Am Coll Cardiol; 2006 Oct 03; 48(7):1339-45. PubMed ID: 17010792 [Abstract] [Full Text] [Related]
20. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE). Zubaid M, Rashed WA, Al-Khaja N, Almahmeed W, Al-Lawati J, Sulaiman K, Al-Motarreb A, Amin H, Al-Suwaidi J, Al-Habib K. Saudi Med J; 2008 Feb 03; 29(2):251-5. PubMed ID: 18246236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]